scholarly article | Q13442814 |
meta-analysis | Q815382 |
review article | Q7318358 |
P356 | DOI | 10.1080/1120009X.2017.1338377 |
P698 | PubMed publication ID | 28622734 |
P50 | author | Amin Salehi-Abargouei | Q44434929 |
Rashid Ramazanzadeh | Q53732976 | ||
Nour Amirmozafari | Q59696022 | ||
Ebrahim Kouhsari | Q88241490 | ||
P2093 | author name string | Mansour Sedighi | |
Abed Zahedi Bialvaei | |||
Ali Ghadimi-Daresajini | |||
P2860 | cites work | Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii | Q41847750 |
Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals | Q42281675 | ||
Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. | Q43101848 | ||
Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan | Q43168744 | ||
Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants | Q43985751 | ||
Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial | Q44467386 | ||
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis | Q46060097 | ||
Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii | Q46261076 | ||
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. | Q51811363 | ||
Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. | Q54323673 | ||
Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. | Q54441479 | ||
Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland | Q58305252 | ||
Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 | Q28205309 | ||
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii | Q28257612 | ||
Highly drug-resistant pathogens implicated in burn-associated bacteremia in an Iraqi burn care unit | Q28541745 | ||
Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis. | Q30251739 | ||
Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile. | Q30364773 | ||
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections | Q33416170 | ||
Multidrug resistant Acinetobacter | Q33711902 | ||
Colistin, mechanisms and prevalence of resistance | Q34463689 | ||
Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey | Q34498753 | ||
An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. | Q34579696 | ||
Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures | Q35314755 | ||
Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens | Q35561864 | ||
Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis. | Q35995536 | ||
Global challenge of multidrug-resistant Acinetobacter baumannii | Q36095081 | ||
Genotypic and Antimicrobial Susceptibility of Carbapenem-resistant Acinetobacter baumannii: Analysis of is Aba Elements and bla OXA-23-like Genes Including a New Variant. | Q36275184 | ||
The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. | Q36949518 | ||
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model | Q37036489 | ||
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options | Q37150308 | ||
Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of iran | Q37663353 | ||
Treatment of Acinetobacter infections | Q37704397 | ||
Multiresistant Acinetobacter baumannii infections: epidemiology and management | Q37767998 | ||
Integrons. | Q37779789 | ||
Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections | Q37811723 | ||
Confronting multidrug-resistant Acinetobacter baumannii: a review | Q37815829 | ||
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options | Q37960325 | ||
Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria | Q38240977 | ||
In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis | Q38281370 | ||
Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: comparison of burn and non-burn strains. | Q39334067 | ||
Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran | Q39475956 | ||
Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. | Q39865670 | ||
Device-associated infection rates and bacterial resistance in six academic teaching hospitals of Iran: Findings from the International Nocosomial Infection Control Consortium (INICC). | Q40886222 | ||
Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. | Q41215969 | ||
P433 | issue | 6 | |
P921 | main subject | Iran | Q794 |
multiple drug resistance | Q643839 | ||
Acinetobacter baumannii | Q3241189 | ||
P304 | page(s) | 327-337 | |
P577 | publication date | 2017-06-16 | |
P1433 | published in | Journal of Chemotherapy | Q15754073 |
P1476 | title | Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis | |
P478 | volume | 29 |